{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:28:15Z","timestamp":1789716495383,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12185-018-2465-8","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T06:49:27Z","timestamp":1525762167000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety of intra-articular transplantation of lentivirally transduced mesenchymal stromal cells for haemophilic arthropathy in a non-human primate"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5082-6394","authenticated-orcid":false,"given":"Tsukasa","family":"Ohmori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Katakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoyasu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsugumine","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"2465_CR1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/asheducation.V2012.1.362.3798344","volume":"2012","author":"G Young","year":"2012","unstructured":"Young G. New challenges in hemophilia: long-term outcomes and complications. Hematol Am Soc Hematol Educ Program. 2012;2012:362\u20138.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"Suppl 4","key":"2465_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/hae.12429","volume":"20","author":"A Srivastava","year":"2014","unstructured":"Srivastava A. Haemophilia care\u2014beyond the treatment guidelines. Haemophilia. 2014;20(Suppl 4):4\u201310.","journal-title":"Haemophilia"},{"issue":"Suppl 5","key":"2465_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/hae.12993","volume":"22","author":"H van den MarijkeBerg","year":"2016","unstructured":"Marijke van den Berg H. Preventing bleeds by treatment: new era for haemophilia changing the paradigm. Haemophilia. 2016;22(Suppl 5):9\u201313.","journal-title":"Haemophilia"},{"key":"2465_CR4","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","volume":"377","author":"LA George","year":"2017","unstructured":"George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, et al. Hemophilia B gene therapy with a high-specific-activity factor IX variant. N Engl J Med. 2017;377:2215\u201327.","journal-title":"N Engl J Med"},{"key":"2465_CR5","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","volume":"377","author":"S Rangarajan","year":"2017","unstructured":"Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, et al. AAV5-factor VIII gene transfer in severe hemophilia A. N Engl J Med. 2017;377:2519\u201330.","journal-title":"N Engl J Med"},{"key":"2465_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/hae.12959","volume":"22","author":"A Nijdam","year":"2016","unstructured":"Nijdam A, Foppen W, van der Schouw YT, Mauser-Bunschoten EP, Schutgens RE, Fischer K. Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia. Haemophilia. 2016;22:852\u20138.","journal-title":"Haemophilia"},{"key":"2465_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/hae.13201","volume":"23","author":"J Hanley","year":"2017","unstructured":"Hanley J, McKernan A, Creagh MD, Classey S, McLaughlin P, Goddard N, et al. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: a United Kingdom Haemophilia Centre Doctors\u2019 Organisation (UKHCDO) guideline. Haemophilia. 2017;23:511\u201320.","journal-title":"Haemophilia"},{"key":"2465_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","volume":"115","author":"AE Pulles","year":"2017","unstructured":"Pulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017;115:192\u20139.","journal-title":"Pharmacol Res"},{"issue":"Suppl 1","key":"2465_CR9","first-page":"S133-42","volume":"13","author":"T Ohmori","year":"2015","unstructured":"Ohmori T, Mizukami H, Ozawa K, Sakata Y, Nishimura S. New approaches to gene and cell therapy for hemophilia. J Thromb Haemost. 2015;13(Suppl 1):S133-42.","journal-title":"J Thromb Haemost"},{"key":"2465_CR10","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1111\/j.1538-7836.2012.04851.x","volume":"10","author":"Y Kashiwakura","year":"2012","unstructured":"Kashiwakura Y, Ohmori T, Mimuro J, Yasumoto A, Ishiwata A, Sakata A, et al. Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice. J Thromb Haemost. 2012;10:1802\u201313.","journal-title":"J Thromb Haemost"},{"key":"2465_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.thromres.2005.11.006","volume":"118","author":"A Ishiwata","year":"2006","unstructured":"Ishiwata A, Mimuro J, Kashiwakura Y, Niimura M, Takano K, Ohmori T, et al. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene. Thromb Res. 2006;118:627\u201335.","journal-title":"Thromb Res"},{"key":"2465_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2859-10-15","volume":"10","author":"HG Menzella","year":"2011","unstructured":"Menzella HG. Comparison of two codon optimization strategies to enhance recombinant protein production in Escherichia coli. Microb Cell Fact. 2011;10:15.","journal-title":"Microb Cell Fact"},{"key":"2465_CR13","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/sj.gt.3301579","volume":"8","author":"J Mimuro","year":"2001","unstructured":"Mimuro J, Muramatsu S, Hakamada Y, Mori K, Kikuchi J, Urabe M, et al. Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter. Gene Ther. 2001;8:1690\u20137.","journal-title":"Gene Ther"},{"key":"2465_CR14","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1096\/fj.05-5161fje","volume":"20","author":"T Ohmori","year":"2006","unstructured":"Ohmori T, Mimuro J, Takano K, Madoiwa S, Kashiwakura Y, Ishiwata A, et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy. FASEB J. 2006;20:1522\u20134.","journal-title":"FASEB J"},{"key":"2465_CR15","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood-2012-10-462200","volume":"121","author":"J McIntosh","year":"2013","unstructured":"McIntosh J, Lenting PJ, Rosales C, Lee D, Rabbanian S, Raj D, et al. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. Blood. 2013;121:3335\u201344.","journal-title":"Blood"},{"key":"2465_CR16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1182\/blood-2010-05-282707","volume":"117","author":"NJ Ward","year":"2011","unstructured":"Ward NJ, Buckley SM, Waddington SN, Vandendriessche T, Chuah MK, Nathwani AC, et al. Codon optimization of human factor VIII cDNAs leads to high-level expression. Blood. 2011;117:798\u2013807.","journal-title":"Blood"},{"key":"2465_CR17","first-page":"CD003429","volume":"9","author":"A Iorio","year":"2011","unstructured":"Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev. 2011;9:CD003429.","journal-title":"Cochrane Database Syst Rev"},{"key":"2465_CR18","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1182\/blood-2017-08-742312","volume":"130","author":"VR Arruda","year":"2017","unstructured":"Arruda VR, Doshi BS, Samelson-Jones BJ. Novel approaches to hemophilia therapy: successes and challenges. Blood. 2017;130:2251\u20136.","journal-title":"Blood"},{"key":"2465_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415\u20139.","journal-title":"Science"},{"key":"2465_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMra032207","volume":"350","author":"MP McCormack","year":"2004","unstructured":"McCormack MP, Rabbitts TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2004;350:913\u201322.","journal-title":"N Engl J Med"},{"key":"2465_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1089\/hum.2015.137","volume":"27","author":"M Cavazzana","year":"2016","unstructured":"Cavazzana M, Six E, Lagresle-Peyrou C, Andre-Schmutz I, Hacein-Bey-Abina S. Gene therapy for X-linked severe combined immunodeficiency: where do we stand? Hum Gene Ther. 2016;27:108\u201316.","journal-title":"Hum Gene Ther"},{"key":"2465_CR22","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1371\/journal.pbio.0020423","volume":"2","author":"P Hematti","year":"2004","unstructured":"Hematti P, Hong BK, Ferguson C, Adler R, Hanawa H, Sellers S, et al. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2004;2:e423.","journal-title":"PLoS Biol"},{"key":"2465_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol. 2006;24:687\u201396.","journal-title":"Nat Biotechnol"},{"key":"2465_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","volume":"72","author":"EW Alton","year":"2017","unstructured":"Alton EW, Beekman JM, Boyd AC, Brand J, Carlon MS, Connolly MM, et al. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis. Thorax. 2017;72:137\u201347.","journal-title":"Thorax"},{"key":"2465_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/hum.2009.048","volume":"20","author":"Y Ikeda","year":"2009","unstructured":"Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno R, Murakami Y, Murata T, et al. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates. Hum Gene Ther. 2009;20:943\u201354.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2465_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcyt.2017.08.009","volume":"20","author":"H Ireland","year":"2018","unstructured":"Ireland H, Gay MHP, Baldomero H, De Angelis B, Baharvand H, Lowdell MW, et al. The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015. Cytotherapy. 2018;20(1):1\u201320.","journal-title":"Cytotherapy"},{"key":"2465_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.exphem.2011.09.001","volume":"39","author":"CD Porada","year":"2011","unstructured":"Porada CD, Sanada C, Kuo CJ, Colletti E, Mandeville W, Hasenau J, et al. Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC. Exp Hematol. 2011;39:1124\u201335 e4.","journal-title":"Exp Hematol"},{"key":"2465_CR28","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1097\/TP.0000000000001773","volume":"101","author":"EM Sokal","year":"2017","unstructured":"Sokal EM, Lombard CA, Roelants V, Najimi M, Varma S, Sargiacomo C, et al. Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia A patient. Transplantation. 2017;101:1845\u201351.","journal-title":"Transplantation"},{"key":"2465_CR29","doi-asserted-by":"publisher","first-page":"e49450","DOI":"10.1371\/journal.pone.0049450","volume":"7","author":"Y Kashiwakura","year":"2012","unstructured":"Kashiwakura Y, Mimuro J, Onishi A, Iwamoto M, Madoiwa S, Fuchimoto D, et al. Porcine model of hemophilia A. PLoS One. 2012;7:e49450.","journal-title":"PLoS One"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2465-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:57:53Z","timestamp":1589450273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2465"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2465-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"17 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Ohmori received research support from Bayer, Dai-ichi Sankyo, Novo Nordisk, and CSL Behring outside of this study. M.I. and T.T. are employees of ID Pharma Inc. All other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}